BR112019010552A2 - sistemas e métodos de pontuação de alerta precoce respiratório - Google Patents
sistemas e métodos de pontuação de alerta precoce respiratório Download PDFInfo
- Publication number
- BR112019010552A2 BR112019010552A2 BR112019010552A BR112019010552A BR112019010552A2 BR 112019010552 A2 BR112019010552 A2 BR 112019010552A2 BR 112019010552 A BR112019010552 A BR 112019010552A BR 112019010552 A BR112019010552 A BR 112019010552A BR 112019010552 A2 BR112019010552 A2 BR 112019010552A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- respiratory
- impedance
- data
- volume
- Prior art date
Links
- 230000000241 respiratory effect Effects 0.000 title claims abstract description 165
- 238000000034 method Methods 0.000 title claims abstract description 77
- 238000011282 treatment Methods 0.000 claims abstract description 23
- 230000036387 respiratory rate Effects 0.000 claims description 70
- 238000009423 ventilation Methods 0.000 claims description 61
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 43
- 201000010099 disease Diseases 0.000 claims description 42
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 24
- 238000004364 calculation method Methods 0.000 claims description 24
- 206010019280 Heart failures Diseases 0.000 claims description 23
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims description 22
- 206010040047 Sepsis Diseases 0.000 claims description 19
- 201000004193 respiratory failure Diseases 0.000 claims description 13
- 208000019693 Lung disease Diseases 0.000 claims description 10
- 206010037423 Pulmonary oedema Diseases 0.000 claims description 10
- 206010038678 Respiratory depression Diseases 0.000 claims description 10
- 230000035764 nutrition Effects 0.000 claims description 10
- 235000016709 nutrition Nutrition 0.000 claims description 10
- 208000005333 pulmonary edema Diseases 0.000 claims description 10
- 208000030886 Traumatic Brain injury Diseases 0.000 claims description 7
- 230000009529 traumatic brain injury Effects 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 3
- 210000004556 brain Anatomy 0.000 claims description 2
- 206010007134 Candida infections Diseases 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 240000000731 Fagus sylvatica Species 0.000 claims 1
- 235000010099 Fagus sylvatica Nutrition 0.000 claims 1
- 230000009469 supplementation Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 135
- 230000029058 respiratory gaseous exchange Effects 0.000 description 94
- 210000004072 lung Anatomy 0.000 description 74
- 210000000038 chest Anatomy 0.000 description 62
- 238000002560 therapeutic procedure Methods 0.000 description 62
- 239000000523 sample Substances 0.000 description 55
- 238000004458 analytical method Methods 0.000 description 46
- 238000012544 monitoring process Methods 0.000 description 43
- 238000012360 testing method Methods 0.000 description 43
- 230000033001 locomotion Effects 0.000 description 36
- 238000004422 calculation algorithm Methods 0.000 description 34
- 230000000747 cardiac effect Effects 0.000 description 33
- 230000000694 effects Effects 0.000 description 31
- 238000002847 impedance measurement Methods 0.000 description 31
- 230000008859 change Effects 0.000 description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 27
- 229910052760 oxygen Inorganic materials 0.000 description 27
- 239000001301 oxygen Substances 0.000 description 27
- 229910002092 carbon dioxide Inorganic materials 0.000 description 25
- 239000003814 drug Substances 0.000 description 25
- 239000004020 conductor Substances 0.000 description 24
- 229940079593 drug Drugs 0.000 description 23
- 210000002417 xiphoid bone Anatomy 0.000 description 23
- 230000036541 health Effects 0.000 description 22
- 238000013125 spirometry Methods 0.000 description 22
- 238000006213 oxygenation reaction Methods 0.000 description 21
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
- 238000004891 communication Methods 0.000 description 17
- 238000001356 surgical procedure Methods 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 15
- 238000005399 mechanical ventilation Methods 0.000 description 15
- 230000007170 pathology Effects 0.000 description 15
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 230000002685 pulmonary effect Effects 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 13
- 238000012549 training Methods 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000007423 decrease Effects 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 208000006673 asthma Diseases 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 238000002640 oxygen therapy Methods 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 238000012216 screening Methods 0.000 description 10
- 210000000115 thoracic cavity Anatomy 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000002596 correlated effect Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000002980 postoperative effect Effects 0.000 description 9
- 238000002106 pulse oximetry Methods 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 206010002091 Anaesthesia Diseases 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 230000037005 anaesthesia Effects 0.000 description 8
- 238000002592 echocardiography Methods 0.000 description 8
- 208000017169 kidney disease Diseases 0.000 description 8
- 230000015654 memory Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 206010035664 Pneumonia Diseases 0.000 description 7
- 208000010378 Pulmonary Embolism Diseases 0.000 description 7
- 206010039897 Sedation Diseases 0.000 description 7
- 230000003542 behavioural effect Effects 0.000 description 7
- 230000003434 inspiratory effect Effects 0.000 description 7
- 230000010355 oscillation Effects 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 230000035479 physiological effects, processes and functions Effects 0.000 description 7
- 230000035882 stress Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 206010014561 Emphysema Diseases 0.000 description 6
- 206010016803 Fluid overload Diseases 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- 208000037656 Respiratory Sounds Diseases 0.000 description 6
- 230000036626 alertness Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000007177 brain activity Effects 0.000 description 6
- 210000003109 clavicle Anatomy 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 230000003166 hypermetabolic effect Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000003533 narcotic effect Effects 0.000 description 6
- 229940124583 pain medication Drugs 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000002627 tracheal intubation Methods 0.000 description 6
- 201000003883 Cystic fibrosis Diseases 0.000 description 5
- 241001433070 Xiphoides Species 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000013123 lung function test Methods 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000036544 posture Effects 0.000 description 5
- 230000004043 responsiveness Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 230000035488 systolic blood pressure Effects 0.000 description 5
- 208000031229 Cardiomyopathies Diseases 0.000 description 4
- 206010019027 Haemothorax Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010021133 Hypoventilation Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 238000005273 aeration Methods 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 238000004820 blood count Methods 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000035487 diastolic blood pressure Effects 0.000 description 4
- 208000000122 hyperventilation Diseases 0.000 description 4
- 230000000870 hyperventilation Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000004199 lung function Effects 0.000 description 4
- 230000000051 modifying effect Effects 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 230000036581 peripheral resistance Effects 0.000 description 4
- 201000003144 pneumothorax Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010037370 Pulmonary contusion Diseases 0.000 description 3
- 208000027790 Rib fracture Diseases 0.000 description 3
- 206010047924 Wheezing Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000004712 air sac Anatomy 0.000 description 3
- 230000000386 athletic effect Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000013211 curve analysis Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 230000010363 phase shift Effects 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000005069 pulmonary fibrosis Diseases 0.000 description 3
- 238000000275 quality assurance Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 210000000779 thoracic wall Anatomy 0.000 description 3
- 230000003519 ventilatory effect Effects 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 235000007575 Calluna vulgaris Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000032862 Clinical Deterioration Diseases 0.000 description 2
- 206010011376 Crepitations Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 206010048612 Hydrothorax Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010038669 Respiratory arrest Diseases 0.000 description 2
- 208000030934 Restrictive pulmonary disease Diseases 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 238000011871 bio-impedance analysis Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 206010006475 bronchopulmonary dysplasia Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 238000002695 general anesthesia Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 238000009613 pulmonary function test Methods 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 230000008354 tissue degradation Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000005740 tumor formation Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010003598 Atelectasis Diseases 0.000 description 1
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 1
- 206010049993 Cardiac death Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 206010051228 Chylothorax Diseases 0.000 description 1
- 206010009691 Clubbing Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 229910019974 CrSi Inorganic materials 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010011906 Death Diseases 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 208000029523 Interstitial Lung disease Diseases 0.000 description 1
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000020241 Neonatal disease Diseases 0.000 description 1
- 208000037129 Newborn Diseases Infant Diseases 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 206010038748 Restrictive cardiomyopathy Diseases 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010001053 acute respiratory failure Diseases 0.000 description 1
- 238000011374 additional therapy Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000695 adrenergic alpha-agonist Substances 0.000 description 1
- 239000000808 adrenergic beta-agonist Substances 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000002160 alpha blocker Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960000794 baclofen Drugs 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000037198 cardiovascular physiology Effects 0.000 description 1
- 238000013131 cardiovascular procedure Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000024980 claudication Diseases 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- -1 hydrocoUoids Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 206010020871 hypertrophic cardiomyopathy Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000001566 impedance spectroscopy Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010416 ion conductor Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 238000000491 multivariate analysis Methods 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000005312 nonlinear dynamic Methods 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003105 phrenic nerve Anatomy 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 230000001144 postural effect Effects 0.000 description 1
- 229940095885 precose Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000013214 routine measurement Methods 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0024—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system for multiple sensor units attached to the patient, e.g. using a body or personal area network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Primary Health Care (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Data Mining & Analysis (AREA)
- Pulmonology (AREA)
- Databases & Information Systems (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662416416P | 2016-11-02 | 2016-11-02 | |
| PCT/US2017/059754 WO2018085563A1 (fr) | 2016-11-02 | 2017-11-02 | Systèmes et procédés de notation d'alerte précoce respiratoire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019010552A2 true BR112019010552A2 (pt) | 2019-09-17 |
Family
ID=62076278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019010552A BR112019010552A2 (pt) | 2016-11-02 | 2017-11-02 | sistemas e métodos de pontuação de alerta precoce respiratório |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3528694A4 (fr) |
| JP (1) | JP2020503085A (fr) |
| KR (1) | KR20190071808A (fr) |
| CN (1) | CN109996488B (fr) |
| AU (1) | AU2017354162A1 (fr) |
| BR (1) | BR112019010552A2 (fr) |
| CA (1) | CA3042686A1 (fr) |
| IL (1) | IL266388B2 (fr) |
| MX (1) | MX2019005195A (fr) |
| WO (1) | WO2018085563A1 (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11160459B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Monitoring health status of people suffering from chronic diseases |
| US10687742B2 (en) | 2015-06-12 | 2020-06-23 | ChroniSense Medical Ltd. | Using invariant factors for pulse oximetry |
| US11160461B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Blood pressure measurement using a wearable device |
| US11464457B2 (en) | 2015-06-12 | 2022-10-11 | ChroniSense Medical Ltd. | Determining an early warning score based on wearable device measurements |
| US10952638B2 (en) | 2015-06-12 | 2021-03-23 | ChroniSense Medical Ltd. | System and method for monitoring respiratory rate and oxygen saturation |
| US11712190B2 (en) | 2015-06-12 | 2023-08-01 | ChroniSense Medical Ltd. | Wearable device electrocardiogram |
| US11000235B2 (en) | 2016-03-14 | 2021-05-11 | ChroniSense Medical Ltd. | Monitoring procedure for early warning of cardiac episodes |
| JP6298919B1 (ja) * | 2017-06-07 | 2018-03-20 | スマート ビート プロフィッツ リミテッド | データベースの構築方法及びデータベース |
| EP3731744B1 (fr) * | 2017-12-26 | 2024-05-22 | ChroniSense Medical Ltd. | Détermination d'un score d'alerte précoce sur la base de mesures de dispositif portable |
| EP3737475A4 (fr) | 2018-02-16 | 2021-03-24 | University Of Louisville Research Foundation, Inc. | Dispositif d'entraînement respiratoire et de surveillance de pression des voies respiratoires |
| US11908581B2 (en) | 2018-04-10 | 2024-02-20 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
| US11504071B2 (en) | 2018-04-10 | 2022-11-22 | Hill-Rom Services, Inc. | Patient risk assessment based on data from multiple sources in a healthcare facility |
| CN108931955B (zh) * | 2018-08-28 | 2023-12-26 | 康泰医学系统（秦皇岛）股份有限公司 | 生理信号的模拟输出装置 |
| US11096582B2 (en) * | 2018-11-20 | 2021-08-24 | Veris Health Inc. | Vascular access devices, systems, and methods for monitoring patient health |
| FR3097424A1 (fr) * | 2019-06-18 | 2020-12-25 | Pharma Dom | Système d’alerte sur tendance en ventilation non invasive |
| JP7381363B2 (ja) * | 2020-02-21 | 2023-11-15 | フクダ電子株式会社 | 生体情報取得装置 |
| CN111681777B (zh) * | 2020-06-05 | 2023-12-19 | 河南省药品评价中心 | 一种基于病史信息的潜在致瘾致幻药品的预警方法 |
| DE102020123601A1 (de) * | 2020-09-10 | 2022-03-10 | Löwenstein Medical Technology S.A. | Koordinationseinheit und Behandlungssystem |
| CN112669957A (zh) * | 2020-11-30 | 2021-04-16 | 四川大学 | 基于肺部疾病的公共卫生安全预警系统 |
| WO2022146860A1 (fr) * | 2021-01-04 | 2022-07-07 | Medtronic, Inc. | Détection d'une infection chez un patient |
| WO2022167065A1 (fr) * | 2021-02-03 | 2022-08-11 | Widex A/S | Procédé permettant de fournir un score d'alerte précoce au moyen d'un système pouvant être porté comportant un dispositif porté sur l'oreille |
| CN112998689B (zh) * | 2021-02-08 | 2022-01-18 | 南京泓鼎感知技术有限责任公司 | 非接触式多人实时呼吸状况评估系统、设备和存储介质 |
| KR102567385B1 (ko) * | 2021-04-26 | 2023-08-16 | (주) 멕아이씨에스 | 뇌파 기반 마취 및 수면 모니터링 장치 및 방법 |
| KR102565228B1 (ko) * | 2021-08-23 | 2023-08-09 | 주식회사 바이랩 | 심폐기능 측정 장치 및 그 방법 |
| WO2023210538A1 (fr) * | 2022-04-26 | 2023-11-02 | ミツフジ株式会社 | Ceinture et vêtement |
| CN114582511B (zh) * | 2022-05-07 | 2022-11-15 | 中国人民解放军总医院第八医学中心 | 一种支气管扩张症急性加重期预警方法、装置、设备及介质 |
| TWI817809B (zh) * | 2022-11-03 | 2023-10-01 | 臺北醫學大學 | 心臟異常事件預警系統以及方法 |
| CN115862301B (zh) * | 2023-02-23 | 2023-05-05 | 深圳市特安电子有限公司 | 一种用于压力变送器的远程智能通讯系统 |
| CN117352165B (zh) * | 2023-12-06 | 2024-02-20 | 深圳市健怡康医疗器械科技有限公司 | 一种老年人术后康复护理方法及系统 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6219408B1 (en) * | 1999-05-28 | 2001-04-17 | Paul Kurth | Apparatus and method for simultaneously transmitting biomedical data and human voice over conventional telephone lines |
| WO2006136972A1 (fr) * | 2005-06-22 | 2006-12-28 | Koninklijke Philips Electronics N.V. | Dispositif de mesure de degre d'acuite instantane de patient |
| US20070123755A1 (en) * | 2005-10-14 | 2007-05-31 | Rice William H | System and Method for Repetitive Interval Clinical Evaluations |
| US8852094B2 (en) * | 2006-12-22 | 2014-10-07 | Masimo Corporation | Physiological parameter system |
| US10667717B2 (en) * | 2011-07-20 | 2020-06-02 | Respiratory Motion, Inc. | Impedance measuring devices and methods for emergency cardiovascular care |
| WO2012021900A1 (fr) * | 2010-08-13 | 2012-02-16 | Respiratory Motion, Inc. | Dispositifs et procédés de surveillance de variation respiratoire grâce à la mesure de volumes respiratoires, de mouvement et de la variabilité |
| AU2015264875B2 (en) * | 2010-08-13 | 2017-10-12 | Respiratory Motion, Inc. | Devices and methods for respiratory variation monitoring by measurement of respiratory volumes, motion and variability |
| GB201018774D0 (en) * | 2010-11-05 | 2010-12-22 | Learning Clinic The Ltd | A system and method for monitoring the health of a hospital patient |
| US10055549B2 (en) * | 2013-10-10 | 2018-08-21 | Wireless Medical Monitoring, Inc. | Method and apparatus for wireless health monitoring and emergent condition prediction |
| EP3215201A4 (fr) * | 2014-11-04 | 2018-07-11 | Respiratory Motion, Inc. | Administration intraveineuse automatisée, guidée par paramètre respiratoire, et activation de pince de tube intraveineux |
| EP3280319A1 (fr) * | 2015-04-08 | 2018-02-14 | Koninklijke Philips N.V. | Score d'avertissement de détérioration cardiovasculaire |
-
2017
- 2017-11-02 MX MX2019005195A patent/MX2019005195A/es unknown
- 2017-11-02 EP EP17867005.5A patent/EP3528694A4/fr active Pending
- 2017-11-02 BR BR112019010552A patent/BR112019010552A2/pt not_active IP Right Cessation
- 2017-11-02 CA CA3042686A patent/CA3042686A1/fr active Pending
- 2017-11-02 KR KR1020197015785A patent/KR20190071808A/ko not_active Application Discontinuation
- 2017-11-02 WO PCT/US2017/059754 patent/WO2018085563A1/fr unknown
- 2017-11-02 CN CN201780068395.0A patent/CN109996488B/zh active Active
- 2017-11-02 JP JP2019523842A patent/JP2020503085A/ja active Pending
- 2017-11-02 AU AU2017354162A patent/AU2017354162A1/en not_active Abandoned
-
2019
- 2019-05-01 IL IL266388A patent/IL266388B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019005195A (es) | 2019-09-19 |
| JP2020503085A (ja) | 2020-01-30 |
| KR20190071808A (ko) | 2019-06-24 |
| CN109996488B (zh) | 2022-11-01 |
| IL266388B1 (en) | 2023-04-01 |
| AU2017354162A1 (en) | 2019-06-06 |
| IL266388A (en) | 2019-06-30 |
| IL266388B2 (en) | 2023-08-01 |
| EP3528694A1 (fr) | 2019-08-28 |
| CN109996488A (zh) | 2019-07-09 |
| EP3528694A4 (fr) | 2020-10-14 |
| WO2018085563A1 (fr) | 2018-05-11 |
| CA3042686A1 (fr) | 2018-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7461072B2 (ja) | 呼吸早期警告スコアリングシステムおよび方法 | |
| CN109996488B (zh) | 呼吸预警评分系统和方法 | |
| US20200329977A1 (en) | Devices and methods for respiratory variation monitoring by measurement of respiratory volumes, motion and variability | |
| US20180280646A1 (en) | Respiratory volume monitor and ventilator | |
| JP2023153893A (ja) | 換気療法システムおよび方法 | |
| AU2017279693B2 (en) | Devices and methods for respiratory variation monitoring by measurement of respiratory volumes, motion and variability | |
| US20200383647A1 (en) | Device and method for clinical evaluation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2642 DE 24-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |